Cargando…
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement
Background. Synthetic vascular graft calcification is a serious complication of graft placement. Here, we analysed migration and osteogenic genes of human umbilical vein endothelial cells (HUVEC) cultured with a poly-L-lactic acid (PLLA) electrospun mat. The role of epigallo-catechin-3-gallate (EGCG...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220276/ https://www.ncbi.nlm.nih.gov/pubmed/35740298 http://dx.doi.org/10.3390/biomedicines10061276 |
_version_ | 1784732333487685632 |
---|---|
author | Ciavarella, Carmen Motta, Ilenia Blando, Santino Valente, Sabrina Farabegoli, Fulvia Focarete, Maria Letizia Gargiulo, Mauro Pasquinelli, Gianandrea |
author_facet | Ciavarella, Carmen Motta, Ilenia Blando, Santino Valente, Sabrina Farabegoli, Fulvia Focarete, Maria Letizia Gargiulo, Mauro Pasquinelli, Gianandrea |
author_sort | Ciavarella, Carmen |
collection | PubMed |
description | Background. Synthetic vascular graft calcification is a serious complication of graft placement. Here, we analysed migration and osteogenic genes of human umbilical vein endothelial cells (HUVEC) cultured with a poly-L-lactic acid (PLLA) electrospun mat. The role of epigallo-catechin-3-gallate (EGCG) in pathogenic processes involving HUVEC and peripheral blood mononuclear cells (PBMCs) was also tested. Methods. HUVEC were cultured in indirect contact with PLLA for 48 h, with or without EGCG, and processed for mRNA expression. HUVEC proliferation, migration and osteogenic differentiation were evaluated after EGCG treatment. EGCG was also administrated to human PBMCs, to analyse proliferation and migration toward HUVEC cultured with PLLA. Results. HUVEC cultured with PLLA exhibited increased expression of SLUG, VIMENTIN, MMP-9 (migration, vascular remodelling) and RUNX-2 (osteogenic transcription factor). EGCG at 25 μM significantly reduced HUVEC migration, osteogenic differentiation, without affecting cell viability, and mitigated PLLA influence on SLUG, MMP-9, VIMENTIN and RUNX-2 expression. EGCG affected PBMC proliferation and migration toward PLLA in a transwell co-culture system with HUVEC. Conclusion. Our study suggests the pro-calcific effect of PLLA, proposing EGCG as an anti-inflammatory modulatory approach. Research efforts need to deepen PLLA-vascular wall interactions for preventing vascular graft failure. |
format | Online Article Text |
id | pubmed-9220276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92202762022-06-24 Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement Ciavarella, Carmen Motta, Ilenia Blando, Santino Valente, Sabrina Farabegoli, Fulvia Focarete, Maria Letizia Gargiulo, Mauro Pasquinelli, Gianandrea Biomedicines Article Background. Synthetic vascular graft calcification is a serious complication of graft placement. Here, we analysed migration and osteogenic genes of human umbilical vein endothelial cells (HUVEC) cultured with a poly-L-lactic acid (PLLA) electrospun mat. The role of epigallo-catechin-3-gallate (EGCG) in pathogenic processes involving HUVEC and peripheral blood mononuclear cells (PBMCs) was also tested. Methods. HUVEC were cultured in indirect contact with PLLA for 48 h, with or without EGCG, and processed for mRNA expression. HUVEC proliferation, migration and osteogenic differentiation were evaluated after EGCG treatment. EGCG was also administrated to human PBMCs, to analyse proliferation and migration toward HUVEC cultured with PLLA. Results. HUVEC cultured with PLLA exhibited increased expression of SLUG, VIMENTIN, MMP-9 (migration, vascular remodelling) and RUNX-2 (osteogenic transcription factor). EGCG at 25 μM significantly reduced HUVEC migration, osteogenic differentiation, without affecting cell viability, and mitigated PLLA influence on SLUG, MMP-9, VIMENTIN and RUNX-2 expression. EGCG affected PBMC proliferation and migration toward PLLA in a transwell co-culture system with HUVEC. Conclusion. Our study suggests the pro-calcific effect of PLLA, proposing EGCG as an anti-inflammatory modulatory approach. Research efforts need to deepen PLLA-vascular wall interactions for preventing vascular graft failure. MDPI 2022-05-30 /pmc/articles/PMC9220276/ /pubmed/35740298 http://dx.doi.org/10.3390/biomedicines10061276 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ciavarella, Carmen Motta, Ilenia Blando, Santino Valente, Sabrina Farabegoli, Fulvia Focarete, Maria Letizia Gargiulo, Mauro Pasquinelli, Gianandrea Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement |
title | Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement |
title_full | Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement |
title_fullStr | Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement |
title_full_unstemmed | Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement |
title_short | Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement |
title_sort | epigallocatechin-3-gallate (egcg) mitigates endothelial and circulating cells alterations following plla electrospun mat placement |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220276/ https://www.ncbi.nlm.nih.gov/pubmed/35740298 http://dx.doi.org/10.3390/biomedicines10061276 |
work_keys_str_mv | AT ciavarellacarmen epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT mottailenia epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT blandosantino epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT valentesabrina epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT farabegolifulvia epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT focaretemarialetizia epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT gargiulomauro epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement AT pasquinelligianandrea epigallocatechin3gallateegcgmitigatesendothelialandcirculatingcellsalterationsfollowingpllaelectrospunmatplacement |